Dr. Greg Riely: How I Use Molecular Marker Information in Earlier Stage NSCLC Patients
4 mar 2013 ·
2 min. 10 sec.
![Dr. Greg Riely: How I Use Molecular Marker Information in Earlier Stage NSCLC Patients](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/ae151e244381c51b7f3b6ca14e8487ee.jpg)
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
Dr. Greg Riely from Memorial Sloan-Kettering notes how he feels molecular marker results for patients with earlier stage lung cancer can potentially be valuable.
Informazioni
Autore | cancerGRACE |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company